Mental Depression in Hypertensive Patients Treated for Long Periods with Large Doses of Reserpine
- 16 December 1954
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 251 (25), 1006-1008
- https://doi.org/10.1056/nejm195412162512504
Abstract
THE introduction of Rauwolfia serpentina into this country by Wilkins and Judson1 and the purification of an active alkaloid, reserpine (Serpasil), has led to the widespread clinical use of the latter drug not only in hypertension2 , 3 but also in neuropsychiatric conditions.4 The purpose of this report is to describe the development of psychiatric complications in hypertensive patients treated with large doses of reserpine for long periods.Case ReportsCase 1. Mrs. I.K., a 54-year-old widow, had mild hypertension for 1 year associated with headache and substernal pain. Since the death of her husband 2 years previously she had been more . . .Keywords
This publication has 4 references indexed in Scilit:
- USE OF RAUWOLFIA SERPENTINA BENTH. IN NEUROPSYCHIATRIC CONDITIONSAnnals of the New York Academy of Sciences, 1954
- CLINICAL AND EXPERIMENTAL EFFECTS OF RESERPINE IN PATIENTS WITH ESSENTIAL HYPERTENSIONAnnals of the New York Academy of Sciences, 1954
- Reserpine in the Treatment of HypertensionNew England Journal of Medicine, 1954
- The Use ofRauwolif serpentinain Hypertensive PatientsNew England Journal of Medicine, 1953